Funding Announcements

"The power of the OXcan proteomics biomarker discovery platform and the data generated by Oxcan stand out against the backdrop of other liquid biopsy companies, indicating a truly superior performance in the identification of early stage lung cancer"

"Most eCommerce brands follow a familiar playbook, drive traffic, offer discounts for email sign-ups, maybe test a traffic de-anonymizer, hope for purchases and remarket those that don't. But this underutilises the most impactful and brief moment for building marketing lists, the checkout. Since focusing on the eCommerce market, we've discovered something extraordinary, when done right, compliance isn't just about protection, it's about growth. By dynamically optimising consent language at the checkout, based on visitor location and marketing channel, we're helping merchants achieve remarkable results in terms of increased opt-in rates, marketing contacts, and additional revenue generated through repeat purchases."

"People living with obesity and its complications deserve better options at each stage of their treatment journey. These include oral therapies with less frequent dosing regimens, which have the potential for improved efficacy and tolerability, and innovative combination therapies for healthier weight loss and—equally importantly—maintenance of metabolically healthy weight. We created Verdiva Bio to accelerate the development of differentiated medicines that address these significant unmet medical needs."